CHNG:NSD-Change Healthcare Inc (USD)

COMMON STOCK | Health Information Services | NSD

Last Closing Price

USD 27.32

Change

0.00 (0.00)%

Market Cap

USD 8.95B

Volume

8.90M

Avg Analyst Target

USD 27.50 (+0.66%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


CHNG Stock Forecast & Price:
Based on the Change Healthcare Inc stock forecasts from 5 analysts, the average analyst target price for Change Healthcare Inc is USD 27.50 over the next 12 months. Change Healthcare Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Change Healthcare Inc is Neutral, which is based on 5 positive signals and 5 negative signals. At the last closing, Change Healthcare Inc’s stock price was USD 27.32. Change Healthcare Inc’s stock price has changed by +7.18% over the past week, +10.21% over the past month and +27.84% over the last year.

About Change Healthcare Inc (CHNG:NSD)

Change Healthcare Inc., an independent healthcare technology company, provides data and analytics-driven solutions to enhance clinical, financial, administrative, and patient engagement outcomes in the United States healthcare system. It operates through three segments: Software ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-09-24 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
RCM R1 RCM Inc

N/A

USD7.96B 57.67 58.54
INOV Inovalon Holdings Inc

N/A

USD6.37B 122.57 33.93
HQY HealthEquity Inc

N/A

USD6.19B 789.30 60.86
PINC Premier Inc

N/A

USD4.03B 15.58 9.65
PRVA Privia Health Group Inc

N/A

USD3.86B N/A -85.55
OMCL Omnicell Inc

N/A

USD3.82B 71.32 28.49
PGNY Progyny Inc

N/A

USD3.41B 88.29 192.10
ONEM 1Life Healthcare Inc

N/A

USD3.34B N/A -12.90
TXG 10X Genomics Inc

N/A

USD3.32B N/A -27.39
HMSY HMS Holdings Corp

N/A

USD3.29B 47.40 23.59

ETFs Containing CHNG

Symbol Name Weight Mer Price(Change) Market Cap
EVFTC Eaton Vance Floating-Rate.. 0.69 % 0.76 %

N/A

USD5.15M
FTSL First Trust Senior Loan F.. 0.00 % 0.86 %

N/A

USD3.14B
MNA IQ Merger Arbitrage ETF 0.00 % 0.76 %

N/A

USD0.56B
SRLN SPDR Blackstone Senior Lo.. 0.00 % 0.70 %

N/A

USD7.98B
AUSF Global X Adaptive U.S. Fa.. 0.00 % 0.27 %

N/A

USD0.16B
PFFD Global X U.S. Preferred E.. 0.00 % 0.23 %

N/A

USD2.02B
EDOC Global X Telemedicine & D.. 0.00 % 0.68 %

N/A

USD0.17B
DDOC:XETRA Global X Telemedicine & D.. 0.00 % 0.68 %

N/A

USD5.60M

Market Performance

  Market Performance vs.
Industry/Classification (Health Information Services)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 27.78% 96% A 97% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.78% 96% A 97% A+
Trailing 12 Months  
Capital Gain 27.84% 96% A 96% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.84% 96% A 96% A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 23.05% 77% C+ 82% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.05% 77% C+ 81% B-
Risk Return Profile  
Volatility (Standard Deviation) 39.85% 44% F 37% F
Risk Adjusted Return 57.82% 90% A- 88% B+
Market Capitalization 8.95B 100% A+ 94% A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Health Information Services)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 2.72 32% F 30% F
Price / Cash Flow Ratio 12.84 30% F 19% F
EV/EBITDA 16.88 24% F 14% F
Management Effectiveness  
Return on Equity -2.35% 69% D+ 54% F
Return on Invested Capital 1.11% 64% D 59% F
Return on Assets 0.86% 70% C- 62% D-
Debt to Equity Ratio 139.80% 9% F 16% F
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 5.75 33% F 26% F
Short Percent 5.81% 31% F 27% F
Beta 1.02 58% F 53% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.